’It isn’t clear’ if aid to airline industry will be enough: former American Airlines CEO

Can Novavax’s Surge Continue Following Positive Data for Flu Vaccine?

If you think the broader market’s extreme pendulum swings are the definition of volatility, you should have a conversation with long-term investors of vaccine specialist Novavax (NVAX). To quickly recap the last 24 months: In 2018, the stock gained 73%, paid it back with interest during a 90% slide in 2019, and is back to gaining again. Unlike most other names, so far in 2020, the small cap biotech is up by a jaw dropping 198%. Yesterday, Novavax added another 20% to its share price. So, the recent surge must be COVID-19 related, right? Well, yes and no. Novavax has received an initial $4 million grant from the CEPI (Coalition for Epidemic Preparedness) to prepare a Phase 1 clinical trial of a COVID-19 vaccine, which is expected to begin in late spring. However, the reason for the latest burst of optimism involves another vaccine the company is developing. On Monday, Novavax...

Moody’s Lowers 3M’s Outlook to Negative From Stable Amid Rising Leverage Risk

Rating agency Moody’s Investors Service changed 3M Company’s (MMM) outlook to negative from stable due to expectations of higher leverage needs and weaker earnings for this year.Moody’s reaffirmed 3M’s A1 senior unsecured debt rating. The rating agency expects the company’s revenue and margins to decline “meaningfully” in 2020 as a result of a protracted period of falling demand exacerbated by the coronavirus crisis.3M has a Moderate Buy analyst consensus rating, based on 3 Buys, 3 Holds, and 1 Sell. The average price target of $165.80 suggests potential room for a 26% gain in the next 12 months. (See 3M’s stock analysis on TipRanks) “3M's exposure to the automobile and electronics end markets, as well as the production and supply chains in China, Korea, and Japan, render the company vulnerable to shifts in market sentiment and operational disruption in these unprecedented times,” Moody’s said in the report.Moody's believes that 3M will continue to...